Abbott Laboratories (ABT)

Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity

Difficulty: Beginner

Annual Data

Quarterly Data

Abbott Laboratories, Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity

	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Short-term borrowings
Trade accounts payable
Salaries, wages and commissions
Accrued rebates payable to government agencies
Accrued other rebates
All other
Other accrued liabilities	%	%	%	%	%
Dividends payable
Income taxes payable
Current portion of long-term debt
Current liabilities held for disposition
Current liabilities	%	%	%	%	%
Long-term debt, excluding current portion
Defined benefit pension plans and post-employment medical and dental plans for significant plans
Deferred income taxes
All other
Post-employment obligations and other long-term liabilities	%	%	%	%	%
Non-current liabilities held for disposition
Non-current liabilities	%	%	%	%	%
Total liabilities	%	%	%	%	%
Preferred shares, one dollar par value, none issued
Common shares, without par value
Common shares held in treasury, at cost
Earnings employed in the business
Accumulated other comprehensive loss
Total Abbott shareholders' investment	%	%	%	%	%
Noncontrolling interests in subsidiaries
Total shareholders' investment	%	%	%	%	%
Total liabilities and shareholders' investment	%	%	%	%	%

	Abbott Laboratories	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality